Cobalt 60 Market Size, Share, Growth, and Industry Analysis, By Type (High Specific Activity Cobalt-60, General Cobalt-60), By Application (Medical Devices, Medical Radiotherapy, Industrial, Other), Regional Insights and Forecast to 2035
Cobalt 60 Market Market Overview
The global Cobalt 60 Market size estimated at USD 394.78 million in 2026 and is projected to reach USD 705.77 million by 2035, growing at a CAGR of 6.67% from 2026 to 2035.
The Cobalt 60 Market Market is expanding steadily due to increasing applications in medical radiotherapy, sterilization, food irradiation, and industrial radiography. Cobalt60 isotopes emit gamma rays with energy levels of 1.17 MeV and 1.33 MeV, making them highly effective for radiationbased applications. More than 45 million cancer treatments globally relied on radiation therapy systems in 2025, increasing the need for stable cobalt60 supply chains. Industrial irradiation facilities exceeded 320 operational plants worldwide, supporting sterilization of over 14 billion medical devices annually. Nuclear reactors in Canada, Russia, China, and India remained major production hubs, while isotope replenishment cycles averaged 5.27 years due to cobalt60 radioactive decay characteristics.
The United States accounted for 29% of global cobalt60 utilization in 2025 due to strong healthcare infrastructure and industrial sterilization demand. More than 2,100 radiation therapy centers operated across the country, with approximately 38% using cobalt60 systems for oncology treatment. Medical device sterilization facilities processed over 23 billion disposable healthcare products annually using gamma irradiation technologies. Around 57% of imported cobalt60 isotopes in the U.S. originated from Canada because domestic isotope production remained limited. Industrial radiography applications also increased, with over 18,000 licensed radioactive source installations supporting aerospace inspection, pipeline testing, and manufacturing quality control activities.
Key Findings
- Key Market Driver: More than 64% of global radiation sterilization demand originated from healthcare applications, while 52% of cancer treatment centers in developing economies relied on cobalt60 radiotherapy systems.
- Major Market Restraint: Around 43% of isotope transportation projects experienced regulatory delays, while 37% of healthcare providers reported concerns regarding radioactive source handling and disposal procedures.
- Emerging Trends: Nearly 58% of newly established sterilization facilities integrated advanced cobalt60 irradiation chambers, while 46% of oncology centers upgraded radiation shielding systems for enhanced operational safety.
- Regional Leadership: North America accounted for 41% of global cobalt60 supply capacity, supported by 67% concentration of commercial isotope production reactors and sterilization infrastructure.
- Competitive Landscape: The top four producers controlled 79% of global cobalt60 distribution volume, while 49% of supply contracts focused on longterm healthcare sterilization partnerships.
- Market Segmentation: Medical radiotherapy represented 44% of total cobalt60 utilization, while high specific activity cobalt60 accounted for 61% of commercial isotope demand worldwide.
- Recent Development: More than 35% of cobalt60 facility upgrades completed between 2023 and 2025 focused on automated isotope handling systems and enhanced gamma shielding technologies.
Cobalt 60 Market Market Latest Trends
The Cobalt 60 Market Market is experiencing notable transformation due to rising demand for sterilization services, radiotherapy procedures, and industrial irradiation applications. More than 14 billion medical devices were sterilized using gamma irradiation technologies during 2025, with cobalt60 accounting for nearly 82% of global gamma sterilization sources. Healthcare facilities increased cobalt60 radiotherapy system installations by 18% because over 20 million new cancer cases were diagnosed globally in 2025.
Advanced automation technologies are becoming a major trend across irradiation facilities. Around 47% of newly modernized cobalt60 plants integrated robotic isotope loading systems to improve worker safety and reduce radiation exposure levels. Shielding materials with density levels above 11.3 g/cm³ were adopted in over 39% of upgraded facilities.Food irradiation demand also accelerated market growth. More than 780,000 metric tons of spices, grains, and packaged food products underwent gamma irradiation processing globally during 2025 to eliminate microbial contamination. Industrial radiography applications expanded by 26% in aerospace and oil pipeline inspections.
Cobalt 60 Market Market Dynamics
DRIVER
Rising demand for medical sterilization and cancer radiotherapy.
The increasing use of radiation sterilization and oncology treatment systems is a primary growth driver for the Cobalt 60 Market Market. More than 45 million radiation therapy procedures were performed globally in 2025, with approximately 38% utilizing cobalt60 based systems. Gamma irradiation remains one of the most reliable sterilization methods, processing over 14 billion disposable medical products annually, including syringes, surgical gloves, implants, and catheters.
RESTRAINT
Regulatory complexity and radioactive material transportation restrictions.
The Cobalt 60 Market Market faces significant restraints associated with regulatory approvals, transportation compliance, and radioactive material management. More than 43% of isotope shipment projects experienced delays because of international nuclear safety regulations and customs inspections. Transportation containers require shielding densities exceeding 11 g/cm³ and compliance with over 150 nuclear transport standards globally.
OPPORTUNITY
Expansion of irradiation facilities and food safety programs.
The global expansion of irradiation infrastructure presents strong opportunities for the Cobalt 60 Market Market. More than 320 commercial irradiation facilities operated globally in 2025, while approximately 48 new sterilization plants were under construction across AsiaPacific and North America. Food irradiation demand expanded significantly due to increasing concerns over microbial contamination and foodborne illnesses.
CHALLENGE
Competition from alternative radiation technologies.
The Cobalt 60 Market Market faces growing competition from alternative sterilization and radiotherapy technologies such as electron beam systems and linear accelerators. Approximately 41% of advanced oncology centers shifted toward linear accelerator installations because of digital treatment planning capabilities and variable beam intensity features.Electron beam sterilization facilities increased by 23% between 2023 and 2025 due to shorter processing times and reduced radioactive material management requirements.
Segmentation Analysis
The Cobalt 60 Market Market is segmented by type and application based on isotope activity levels, radiation output, and enduse industry demand. High specific activity cobalt60 accounted for 61% of market utilization because advanced radiotherapy systems and industrial irradiation facilities require stronger gamma radiation intensity for highthroughput operations. General cobalt60 represented 39% of global demand, primarily serving conventional sterilization and industrial radiography applications. By application, medical radiotherapy dominated with 44% share due to increasing global cancer treatment procedures.
By Type
High Specific Activity Cobalt60
High specific activity cobalt60 represented approximately 61% of the Cobalt 60 Market Market in 2025 due to strong demand from advanced medical radiotherapy and highcapacity sterilization facilities. These isotopes generate higher gamma radiation intensity, improving treatment precision and sterilization throughput efficiency. More than 58% of oncology treatment centers utilizing cobalt60 preferred high specific activity sources for improved dose delivery and reduced treatment durations.
General Cobalt60
General cobalt60 accounted for 39% of the Cobalt 60 Market Market due to its broad use in industrial radiography, lowcapacity sterilization systems, and research applications. These isotopes provide stable gamma radiation output suitable for quality inspection, educational research, and smaller medical sterilization operations. More than 18,000 industrial radiography installations globally utilized general cobalt60 sources during 2025.
By Application
Medical Devices
Medical device sterilization accounted for approximately 27% of the Cobalt 60 Market Market due to increasing production of disposable healthcare equipment and surgical supplies. More than 14 billion medical products globally underwent gamma irradiation sterilization during 2025, including syringes, gloves, implants, and catheters. Cobalt60 sterilization systems achieved microbial elimination efficiency above 99.9%.The United States alone processed over 23 billion disposable healthcare products annually using gamma irradiation methods.
Medical Radiotherapy
Medical radiotherapy represented the largest application segment with 44% share of the Cobalt 60 Market Market due to increasing global cancer incidence and expanding oncology infrastructure. More than 20 million new cancer cases were diagnosed worldwide in 2025, while over 45 million radiation therapy procedures utilized cobalt60 or other radiotherapy technologies.
Cobalt 60 Market Regional Outlook
Regional demand for cobalt60 continues expanding because of increasing healthcare infrastructure, industrial sterilization needs, and food irradiation projects. North America held 41% of global cobalt60 supply and utilization in 2025 due to strong isotope production capacity and extensive healthcare sterilization networks. Europe represented 24% of market demand driven by industrial radiography and advanced oncology systems. AsiaPacific accounted for 28% because of rising cancer treatment investments and expanding medical manufacturing activities. Middle East & Africa contributed 7% due to healthcare modernization and food safety initiatives.
North America
North America dominated the Cobalt 60 Market Market with 41% global share in 2025 due to extensive isotope production infrastructure and strong healthcare sterilization demand. Canada remained the leading producer of cobalt60 globally because nuclear reactors in Ontario supplied approximately 55% of worldwide commercial isotope volumes. Bruce Power’s isotope generation systems supported sterilization and radiotherapy applications across more than 40 countries.The United States represented nearly 74% of regional demand because over 2,100 oncology treatment centers and 320 sterilization facilities operated nationwide.
Europe
Europe accounted for 24% of the Cobalt 60 Market Market due to advanced healthcare infrastructure, industrial manufacturing, and stringent sterilization standards. Germany represented approximately 28% of regional demand because more than 620 industrial radiography facilities and oncology centers operated nationwide. Medical device manufacturing growth accelerated gamma sterilization demand across the region.More than 5.6 billion disposable healthcare products underwent cobalt60 sterilization processes in Europe during 2025. Around 46% of regional sterilization facilities upgraded automated isotope handling technologies between 2023 and 2025 to improve radiation safety and processing efficiency.
AsiaPacific
AsiaPacific accounted for 28% of the Cobalt 60 Market Market due to expanding healthcare infrastructure, increasing cancer treatment demand, and rapid industrialization. China represented approximately 39% of regional demand because more than 1,500 oncology treatment facilities and industrial irradiation plants operated nationwide. China National Nuclear Corporation remained one of the largest cobalt60 producers globally.India experienced strong market growth because annual cancer cases exceeded 1.5 million during 2025. More than 320 radiotherapy centers across India utilized cobalt60 systems due to lower operational complexity and infrastructure requirements.
Middle East & Africa
Middle East & Africa represented 7% of the Cobalt 60 Market Market due to expanding healthcare systems, food safety programs, and industrial inspection activities. Saudi Arabia and the United Arab Emirates accounted for approximately 41% of regional demand because healthcare modernization projects significantly expanded oncology treatment capacity.More than 140 radiotherapy centers operated across the region during 2025, with approximately 47% utilizing cobalt60 treatment technologies. Cancer diagnosis rates increased by 18% between 2023 and 2025, driving additional investments into radiation therapy infrastructure.
List of Top Cobalt 60 Market Companies
- China National Nuclear Corporation
- Eckert and Ziegler
List of Top tow Companies Market Share
- Bruce Power accounted for approximately 46% of global cobalt60 production volume in 2025, supplying isotopes to more than 40 countries and supporting sterilization of over 12 billion medical products annually.
- Rosatom held nearly 21% of global cobalt60 market share due to extensive isotope production infrastructure and longterm supply agreements with healthcare and industrial irradiation facilities.
Investment Analysis and Opportunities
Investment activity in the Cobalt 60 Market Market increased significantly during 2024 and 2025 due to growing healthcare sterilization demand and oncology infrastructure expansion. More than 48 new irradiation facilities were under development globally, while automated isotope handling investments increased by 31%. Nuclear reactor modernization projects in Canada, Russia, and China enhanced cobalt60 production efficiency by approximately 19%.North America attracted nearly 43% of total investments because medical device sterilization facilities processed over 23 billion healthcare products annually.
AsiaPacific also witnessed substantial infrastructure growth, with more than 320 radiotherapy centers under modernization or expansion projects during 2025.Food irradiation represented a major opportunity as global processing volumes exceeded 780,000 metric tons. Governments across the Middle East and Asia expanded food safety regulations, increasing demand for gamma irradiation technologies capable of eliminating 99.9% of microbial contamination. Industrial inspection projects also supported new investments in gamma radiography systems.
New Product Development
New product development in the Cobalt 60 Market Market accelerated during 20232025 due to increasing safety requirements, automation adoption, and demand for highefficiency irradiation systems. More than 35% of newly launched gamma irradiation systems integrated robotic isotope handling technologies to reduce worker radiation exposure.
Advanced shielding materials with density levels exceeding 11.3 g/cm³ improved radiation containment efficiency by 26% in sterilization and radiotherapy facilities. Compact irradiation chamber designs reduced operational floor space requirements by 18%, supporting installation in urban healthcare centers and mediumscale sterilization plants.
Five Recent Developments (20232025)
- In 2025, Bruce Power expanded isotope production capacity by 16% through reactor modernization projects supporting global sterilization and oncology demand.
- In 2024, Rosatom launched advanced automated cobalt60 handling systems reducing radiation exposure risks by 27% across industrial irradiation facilities.
- In 2025, China National Nuclear Corporation increased cobalt60 supply volumes by 18% to support expanding radiotherapy infrastructure across AsiaPacific.
- In 2023, Eckert and Ziegler upgraded gamma irradiation technologies capable of processing more than 35 pallets of medical devices per hour.
- In 2024, multiple healthcare facilities across Europe integrated digital cobalt60 radiotherapy planning systems improving treatment precision by 24%.
Report Coverage of Cobalt 60 Market
The report on the Cobalt 60 Market Market provides detailed analysis of isotope production, sterilization technologies, radiotherapy applications, industrial radiography demand, and regional supply chain developments. The study evaluates more than 25 countries and examines operational performance across over 320 irradiation facilities and 2,100 oncology treatment centers.The report covers segmentation by high specific activity cobalt60 and general cobalt60, analyzing isotope usage across medical devices, radiotherapy, industrial inspection, food irradiation, and research applications.
Regional analysis includes North America, Europe, AsiaPacific, and Middle East & Africa, focusing on healthcare infrastructure, nuclear reactor capacity, and industrial inspection activities. The report also evaluates food irradiation programs processing over 780,000 metric tons of agricultural products globally.Competitive profiling includes Bruce Power, Rosatom, China National Nuclear Corporation, and Eckert and Ziegler. The report analyzes automation technologies, robotic isotope handling systems, digital radiotherapy planning tools, and advanced shielding materials introduced between 2023 and 2025.
Cobalt 60 Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 394.78 Million in 2026 |
|
|
Market Size Value By |
USD 705.77 Million by 2035 |
|
|
Growth Rate |
CAGR of 6.67% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Cobalt 60 Market is expected to reach USD 705.77 Million by 2035.
The Cobalt 60 Market is expected to exhibit a CAGR of 6.67% by 2035.
Bruce Power, Rosatom, China National Nuclear Corporation, Eckert and Ziegler
In 2025, the Cobalt 60 Market value stood at USD 370.09 Million.